Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established InvestigatorsRelease Date:Research Inflammation & Immunology USA Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career InvestigatorsRelease Date:Research Inflammation & Immunology USA 2022 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Innovative Digital Health Projects in OncologyRelease Date:Quality Improvement Oncology Italy BRAF V600-mutant colorectal cancer: disease education and therapy managementEducation Oncology USA Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in CanadaRelease Date:Quality Improvement Rare Disease Canada Establish a System to Refer Patients with Suspected CardiomyopathyRelease Date:Quality Improvement Rare Disease Japan Heart Failure and Cardiomyopathy Leading to Differential Diagnoses of Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Improving the care of patients living with metastatic breast cancer (mBC)Quality Improvement Oncology Canada Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access DisparitiesQuality Improvement Hospital All Promotion of Smoking Cessation Treatment in General PracticeRelease Date:Education Internal Medicine Japan Global ATTR Amyloidosis ResearchRelease Date:Research Rare Disease All